Click to view your profile
Click to search for condition or expert
Click to open main menu
Leukemia Latest Advances
Find the Latest Research About Leukemia
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/06/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2451 publications
See more filters
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia.
Condition:
Acute Myeloid Leukemia (AML)
Journal:
Hematology/oncology and stem cell therapy
Treatment Used:
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Published:
December 20, 2022
VIEW PUBLICATION
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
Condition:
Adults with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Journal:
Journal of hematology & oncology
Treatment Used:
KTE-X19
Number of Patients:
55
Published:
December 09, 2022
VIEW PUBLICATION
Clinical Analysis of Salvage Treatment of Glucocorticoid Resistant Graft-Versus-Host Disease with Vedolizumab in Children.
Condition:
Glucocorticoid Resistant Graft-Versus-Host Disease (GR-GVHD) in Children
Journal:
Zhongguo shi yan xue ye xue za zhi
Treatment Used:
Vedolizumab (VDZ)
Number of Patients:
5
Published:
December 08, 2022
VIEW PUBLICATION
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.
Condition:
Acute Myeloid Leukemia (AML)
Journal:
Clinical lymphoma, myeloma & leukemia
Treatment Used:
Maintenance Therapy
Published:
December 01, 2022
VIEW PUBLICATION
An experience with ibrutinib monotherapy for Richter's syndrome isolated in the central nervous system.
Condition:
Richeter's Syndrome (RS)
Journal:
Journal of clinical and experimental hematopathology : JCEH
Treatment Used:
Ibrutinib
Number of Patients:
1
Published:
November 27, 2022
VIEW PUBLICATION
Search for Synergistic Drug Combinations to Treat Chronic Lymphocytic Leukemia.
Condition:
Chronic Lymphocytic Leukemia
Journal:
Cells
Treatment Used:
Proteasome and mTORC1 Inhibitors
Published:
November 26, 2022
VIEW PUBLICATION
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).
Condition:
Acute Promyelocytic Leukemia (APL)
Journal:
Blood cancer journal
Treatment Used:
All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) vs. All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) Plus Chemotherapy (CHT)
Number of Patients:
128
Published:
November 20, 2022
VIEW PUBLICATION
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.
Condition:
High-Risk Classic Hodgkin Lymphoma
Journal:
The Lancet. Haematology
Treatment Used:
Brentuximab Vedotin Plus Nivolumab
Number of Patients:
59
Published:
November 20, 2022
VIEW PUBLICATION
Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia.
Condition:
Pediatric Acute Leukemia
Journal:
BMC cancer
Treatment Used:
Posttransplant Cyclophosphamide (PTCY)
Number of Patients:
52
Published:
November 19, 2022
VIEW PUBLICATION
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.
Condition:
Philadelphia Chromosome-Positive (Ph-positive) Acute Lymphoblastic Leukemia
Journal:
The Lancet. Haematology
Treatment Used:
Ponatinib and Blinatumomab
Number of Patients:
72
Published:
November 19, 2022
VIEW PUBLICATION
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Condition:
Previously Treated B-Cell Malignancies
Journal:
The Lancet. Haematology
Treatment Used:
Zanubrutinib
Number of Patients:
67
Published:
November 18, 2022
VIEW PUBLICATION
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
Condition:
Relapsed/Refractory Multiple Myeloma (RRMM)
Journal:
Clinical lymphoma, myeloma & leukemia
Treatment Used:
Ciltacabtagene Autoleucel
Number of Patients:
36
Published:
November 10, 2022
VIEW PUBLICATION
Showing 1-12 of 2,451
Next
Last Updated: 01/06/2023